Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanna Cappelli

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Therapeutics and Clinical Risk Management|July 2, 2020
Behçet's Disease in Children: Diagnostic and Management ChallengesGiorgio Costagliola, Susanna Cappelli, Rita Consolini
Journal of Clinical Medicine|October 23, 2021
Autoimmunity in Primary Immunodeficiency Disorders: An Updated Review on Pathogenic and Clinical ImplicationsGiorgio Costagliola, Susanna Cappelli, Rita Consolini
Rheumatology (Oxford, England)|November 5, 2013
Is immunosuppressive therapy the anchor treatment to achieve remission in systemic sclerosis?Susanna Cappelli, Silvia Bellando-Randone, Serena Guiducci, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|September 3, 2013
Immunosuppression for interstitial lung disease in systemic sclerosisSusanna Cappelli, Serena Guiducci, Silvia Bellando Randone, et al.
Frontiers in Genetics|August 6, 2019
Familial Interstitial 6q23.2 Deletion Including Eya4 Associated With Otofaciocervical SyndromeSimone Gana, Angelo Valetto, Benedetta Toschi, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|September 2, 2015
Interstitial lung disease in systemic sclerosis: where do we stand?Susanna Cappelli, Silvia Bellando Randone, Gianna Camiciottoli, et al.
Journal of Clinical Medicine|September 28, 2023
Ataxia Telangiectasia Arising as Immunodeficiency: The Intriguing Differential DiagnosisFederica Cavone, Susanna Cappelli, Alice Bonuccelli, et al.
Frontiers in Pediatrics|May 9, 2024
Case Report: Efficacy, safety, and favorable long-term outcome of early treatment with IL-1 inhibitors in a patient with chronic infantile neurological cutaneous articular (CINCA) syndrome caused by NLRP3 mosaicismGiorgio Costagliola, Sofia D'Elios, Susanna Cappelli, et al.
Frontiers in Pediatrics|January 3, 2022
Toward the Knowledge of the Epidemiological Impact of Acute Rheumatic Fever in ItalyAntonino Maria Quintilio Alberio, Filippo Pieroni, Alessandro Di Gangi, et al.
The Journal of Rheumatology|January 30, 2010
Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patientsJérôme Avouac, Paolo Airò, Philippe Dieude, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Therapeutics and Clinical Risk Management|July 2, 2020
Behçet's Disease in Children: Diagnostic and Management ChallengesGiorgio Costagliola, Susanna Cappelli, Rita Consolini
Journal of Clinical Medicine|October 23, 2021
Autoimmunity in Primary Immunodeficiency Disorders: An Updated Review on Pathogenic and Clinical ImplicationsGiorgio Costagliola, Susanna Cappelli, Rita Consolini
Rheumatology (Oxford, England)|November 5, 2013
Is immunosuppressive therapy the anchor treatment to achieve remission in systemic sclerosis?Susanna Cappelli, Silvia Bellando-Randone, Serena Guiducci, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|September 3, 2013
Immunosuppression for interstitial lung disease in systemic sclerosisSusanna Cappelli, Serena Guiducci, Silvia Bellando Randone, et al.
Frontiers in Genetics|August 6, 2019
Familial Interstitial 6q23.2 Deletion Including Eya4 Associated With Otofaciocervical SyndromeSimone Gana, Angelo Valetto, Benedetta Toschi, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|September 2, 2015
Interstitial lung disease in systemic sclerosis: where do we stand?Susanna Cappelli, Silvia Bellando Randone, Gianna Camiciottoli, et al.
Journal of Clinical Medicine|September 28, 2023
Ataxia Telangiectasia Arising as Immunodeficiency: The Intriguing Differential DiagnosisFederica Cavone, Susanna Cappelli, Alice Bonuccelli, et al.
Frontiers in Pediatrics|May 9, 2024
Case Report: Efficacy, safety, and favorable long-term outcome of early treatment with IL-1 inhibitors in a patient with chronic infantile neurological cutaneous articular (CINCA) syndrome caused by NLRP3 mosaicismGiorgio Costagliola, Sofia D'Elios, Susanna Cappelli, et al.
Frontiers in Pediatrics|January 3, 2022
Toward the Knowledge of the Epidemiological Impact of Acute Rheumatic Fever in ItalyAntonino Maria Quintilio Alberio, Filippo Pieroni, Alessandro Di Gangi, et al.
The Journal of Rheumatology|January 30, 2010
Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patientsJérôme Avouac, Paolo Airò, Philippe Dieude, et al.
Pageof 2